MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-17-2025
AIM ImmunoTech Cash and Cash Equivalents 2011-2026 | AIM
Annual Cash and Cash Equivalents AIM ImmunoTech
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 27.1 M | 32.1 M | 38.5 M | 1.47 M | 299 K | 1.41 M | 2.41 M | 2.12 M | 2.16 M | 803 K | 2.21 M | 3.1 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 38.5 M | 299 K | 9.47 M |
Quarterly Cash and Cash Equivalents AIM ImmunoTech
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.35 M | 476 K | 898 K | 1.7 M | 915 K | 3.55 M | 3.3 M | 5.44 M | 15.3 M | 21 M | - | 27.1 M | 29.8 M | 34.5 M | 29 M | 32.1 M | 37.3 M | 41.1 M | 48.8 M | 38.5 M | 38.5 M | 38.5 M | 38.5 M | 1.47 M | 1.47 M | 1.47 M | 1.47 M | 299 K | 299 K | 299 K | 299 K | 1.41 M | 1.41 M | 1.41 M | 1.41 M | 2.41 M | 2.41 M | 2.41 M | 2.41 M | 2.12 M | 2.12 M | 2.12 M | 2.12 M | 2.16 M | 2.16 M | 2.16 M | 2.16 M | 803 K | 803 K | 803 K | 803 K | 2.21 M | 2.21 M | 2.21 M | 2.21 M | 3.1 M | 3.1 M | 3.1 M | 3.1 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 48.8 M | 299 K | 9.53 M |
Cash and Cash Equivalents of other stocks in the Biotechnology industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
158 M | - | 2.43 % | $ 254 M |  Germany |
 |
Acer Therapeutics
ACER
|
2.33 M | - | 2.71 % | $ 14 M |  USA |
 |
Acorda Therapeutics
ACOR
|
30 M | - | -24.86 % | $ 820 K | USA |
 |
ADMA Biologics
ADMA
|
87.6 M | $ 15.87 | -4.08 % | $ 3.78 B | USA |
 |
AgeX Therapeutics
AGE
|
345 K | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
85.7 M | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
46.4 M | - | - | $ 26.5 M | USA |
 |
AbCellera Biologics
ABCL
|
129 M | $ 3.54 | -2.62 % | $ 1.06 B |  Canada |
 |
I-Mab
IMAB
|
4.76 B | - | - | $ 866 M |  China |
 |
Biophytis SA
BPTS
|
5.57 M | - | -13.47 % | $ 169 M |  France |
 |
Aptorum Group Limited
APM
|
3.5 M | $ 0.82 | -0.73 % | $ 4.47 M | China |
 |
Midatech Pharma plc
MTP
|
1.67 M | - | -18.52 % | $ 27.3 M |  Britain |
 |
Akero Therapeutics
AKRO
|
340 M | - | - | $ 3.67 B | USA |
 |
Akouos
AKUS
|
122 M | - | 0.23 % | $ 488 M | USA |
 |
Alpine Immune Sciences
ALPN
|
13.4 M | - | - | $ 2.17 B | USA |
 |
AlloVir
ALVR
|
118 M | - | 4.14 % | $ 49.1 M | USA |
 |
Apellis Pharmaceuticals
APLS
|
466 M | $ 20.36 | 2.49 % | $ 2.57 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
4.09 M | - | -11.43 % | $ 502 K | USA |
 |
ANI Pharmaceuticals
ANIP
|
145 M | $ 75.13 | -1.83 % | $ 1.45 B | USA |
 |
Applied Therapeutics
APLT
|
49.9 M | - | - | $ 8.42 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
240 M | $ 1.51 | -7.36 % | $ 385 M | Britain |
 |
Aravive
ARAV
|
53.7 M | - | -13.39 % | $ 1.45 M | USA |
 |
Adverum Biotechnologies
ADVM
|
60.7 M | - | - | $ 86.2 M | USA |
 |
Athersys
ATHX
|
37.4 M | - | 3.77 % | $ 22.4 M | USA |
 |
ARCA biopharma
ABIO
|
61.6 M | - | 1052.0 % | $ 415 M | USA |
 |
AVEO Pharmaceuticals
AVEO
|
70.5 M | - | - | $ 521 M | USA |
 |
Axsome Therapeutics
AXSM
|
323 M | $ 162.19 | -1.15 % | $ 8.07 B | USA |
 |
BridgeBio Pharma
BBIO
|
570 M | $ 64.72 | -2.73 % | $ 12.4 B | USA |
 |
Brainstorm Cell Therapeutics
BCLI
|
187 K | - | -2.5 % | $ 5.88 M | USA |
 |
BioDelivery Sciences International
BDSI
|
112 M | - | -4.8 % | $ 255 M | USA |
 |
Acasti Pharma
ACST
|
22.1 M | - | 4.01 % | $ 150 M | Canada |
 |
BeiGene, Ltd.
BGNE
|
4.55 B | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Bellicum Pharmaceuticals
BLCM
|
21.8 M | - | -9.72 % | $ 5.89 M | USA |
 |
Berkeley Lights
BLI
|
86.5 M | - | -7.31 % | $ 87 M | USA |
 |
CureVac N.V.
CVAC
|
811 M | - | - | $ 867 M | Germany |
 |
Aeterna Zentaris
AEZS
|
16.4 M | - | 5.93 % | $ 314 M | Canada |
 |
Bellerophon Therapeutics
BLPH
|
6.92 M | - | -74.18 % | $ 955 K | USA |
 |
BioLineRx Ltd.
BLRX
|
10.4 M | $ 2.86 | 1.78 % | $ 908 M |  Israel |
 |
BioMarin Pharmaceutical
BMRN
|
1.31 B | $ 60.15 | -0.46 % | $ 11.5 B | USA |
 |
Equillium
EQ
|
23.2 M | $ 1.7 | -3.14 % | $ 59 M | USA |
 |
Burford Capital Limited
BUR
|
322 M | $ 8.29 | -1.02 % | $ 1.35 B | Britain |
 |
Cabaletta Bio
CABA
|
193 M | $ 3.3 | -3.89 % | $ 3.85 M | USA |
 |
AIkido Pharma
AIKI
|
4.08 M | - | 1.93 % | $ 17.4 M | USA |
 |
Agenus
AGEN
|
76.1 M | $ 3.02 | -5.63 % | $ 1.08 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
2.41 M | - | - | $ 7.46 M | Israel |
 |
Capricor Therapeutics
CAPR
|
14.7 M | $ 25.16 | -1.33 % | $ 674 M | USA |
 |
Agios Pharmaceuticals
AGIO
|
89.1 M | $ 27.77 | -1.49 % | $ 1.61 B | USA |